Company / Revenue
Omnicell Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$1.2B
FY2025
5-year range
$892.2M / $1.2B
FY2021-FY2025
Trend
+6.5%
vs FY2024
Sector context
#98 of 156
Health Care
What the data says
At $1.2B, Omnicell's revenue ranks #98 of 156 in the Health Care sector. Revenue has fluctuated over the past 10 years, ranging from $441M in FY2016 to $1.2B in FY2025.
Based on SEC 10-K filings.
$1.2B in FY2025 with a 5-year CAGR of +8.5%.
Improved from $1.1B to $1.2B over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +9.9%
- 5-Year CAGR
- +8.5%
- 10-Year CAGR
- -
Sector benchmark
#98 of 156 in Health CareTop 63% of 156This company $1.2B Sector average $19.0B
▼
-93.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +8.5%, indicating consistent growth.
- In FY2025, revenue increased 6.5% year-over-year.
- Ranks #98 out of 156 companies in the Health Care sector.
- Lowest revenue in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.2B | +6.5% |
| FY2024 | $1.1B | -3.0% |
| FY2023 | $1.1B | +28.6% |
| FY2022 | $892.2M | -0.5% |
| FY2021 | $897.0M | +13.9% |
| FY2020 | $787.3M | +10.5% |
| FY2019 | $712.7M | -9.5% |
| FY2018 | $787.3M | +10.5% |
| FY2017 | $712.7M | +61.6% |
| FY2016 | $440.9M | -9.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026